Search
for
Sort by
Research 661–690 of 1000+
- Особливості перебігу симптомів нижніх сечових шляхів у чоловіків із доброякісною гіперплазією передміхурової залози та COVID-19
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Covid-19 in Lupus Nephritis
- COVID-19: A wake-up call for teledermatology in India
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium – The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- COVID-19 Considerations
- COVID-19 Clinical Outcomes and Nationality: Results from a Nationwide Registry in Kuwait
- Co-Relation Between Androgenetic Alopecia and Severity of COVID-19 Disease – A Cross-Sectional Study
- Hospitalized COVID-19 Androgenetic Alopecia JAAD data age group comparison with other references
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data
- The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors
- Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis
- Post‐COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- Alopecia in patients with COVID-19: A systematic review and meta-analysis
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
- Self-reported long COVID-19 symptoms are rare among vaccinated healthcare workers
- Post-COVID-19 syndrome among hospitalized COVID-19 patients: a cohort study assessing patients 6 and 12 months after hospital discharge
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
- Long-COVID-19 clinical and health outcomes: an umbrella review
- Differentiated approach to the implementation of preventive and anti-epidemic measures among military personnel based on the COVID-19 disease risk assessment scale
- Long COVID-19 Effects (Chronic Covid-19 syndrome) in Nepalese Cohort recovered from SARS-CoV-2 infection
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients
- The COVID-19 pandemic and its skin effects
- Black dots in trichoscopy after COVID‐19. Can it be telogen effluvium?
- Análise da qualidade de vida em indivíduos com alopecia pós-COVID-19
- The Immun System Response İn Covıd-19 Infectıon İn Polycystıc Ovary Syndrome
- POST COVID-19 TELOGEN EFFLUVIUM. WHAT IS THE REASON?